1 Market Overview
1.1 EPA / DHA/ALA (Omega 3) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global EPA / DHA/ALA (Omega 3) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Fish Oil
1.2.3 Algae Oil
1.3 Market Analysis by Application
1.3.1 Overview: Global EPA / DHA/ALA (Omega 3) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Dietary Supplements
1.3.3 Functional Foods & Beverages
1.3.4 Others
1.4 Overview of Global EPA / DHA/ALA (Omega 3) Market
1.4.1 Global EPA / DHA/ALA (Omega 3) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: EPA / DHA/ALA (Omega 3) Industry Impact
1.6.1 COVID-19 Potential Implications for the EPA / DHA/ALA (Omega 3)
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on EPA / DHA/ALA (Omega 3)
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 EPAX
2.1.1 EPAX Details
2.1.2 EPAX Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 EPAX SWOT Analysis
2.1.4 EPAX Product and Services
2.1.5 EPAX EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Polaris
2.2.1 Polaris Details
2.2.2 Polaris Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Polaris SWOT Analysis
2.2.4 Polaris Product and Services
2.2.5 Polaris EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Omega Protein
2.3.1 Omega Protein Details
2.3.2 Omega Protein Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Omega Protein SWOT Analysis
2.3.4 Omega Protein Product and Services
2.3.5 Omega Protein EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Golden Omega
2.4.1 Golden Omega Details
2.4.2 Golden Omega Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Golden Omega SWOT Analysis
2.4.4 Golden Omega Product and Services
2.4.5 Golden Omega EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GC Rieber
2.5.1 GC Rieber Details
2.5.2 GC Rieber Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GC Rieber SWOT Analysis
2.5.4 GC Rieber Product and Services
2.5.5 GC Rieber EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 TASA
2.6.1 TASA Details
2.6.2 TASA Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 TASA Product and Services
2.6.4 TASA EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 KD Pharma
2.7.1 KD Pharma Details
2.7.2 KD Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 KD Pharma Product and Services
2.7.4 KD Pharma EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Croda
2.8.1 Croda Details
2.8.2 Croda Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Croda Product and Services
2.8.4 Croda EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Auqi
2.9.1 Auqi Details
2.9.2 Auqi Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Auqi Product and Services
2.9.4 Auqi EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global EPA / DHA/ALA (Omega 3) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global EPA / DHA/ALA (Omega 3) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 EPA / DHA/ALA (Omega 3) Manufacturer Market Share in 2019
3.3.2 Top 6 EPA / DHA/ALA (Omega 3) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Regions
4.1.1 Global EPA / DHA/ALA (Omega 3) Sales and Market Share by Regions (2015-2020)
4.1.2 Global EPA / DHA/ALA (Omega 3) Revenue and Market Share by Regions (2015-2020)
4.2 North America EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
4.3 Europe EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
4.5 South America EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Country
5.1.1 North America EPA / DHA/ALA (Omega 3) Sales and Market Share by Country (2015-2020)
5.1.2 North America EPA / DHA/ALA (Omega 3) Revenue and Market Share by Country (2015-2020)
5.2 United States EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
5.3 Canada EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
5.4 Mexico EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Country
6.1.1 Europe EPA / DHA/ALA (Omega 3) Sales and Market Share by Country (2015-2020)
6.1.2 Europe EPA / DHA/ALA (Omega 3) Revenue and Market Share by Country (2015-2020)
6.2 Germany EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6.3 UK EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6.4 France EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6.5 Russia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
6.6 Italy EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific EPA / DHA/ALA (Omega 3) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific EPA / DHA/ALA (Omega 3) Revenue and Market Share by Regions (2015-2020)
7.2 China EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.3 Japan EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.4 Korea EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.5 India EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
7.7 Australia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Country
8.1.1 South America EPA / DHA/ALA (Omega 3) Sales and Market Share by Country (2015-2020)
8.1.2 South America EPA / DHA/ALA (Omega 3) Revenue and Market Share by Country (2015-2020)
8.2 Brazil EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
8.3 Argentina EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa EPA / DHA/ALA (Omega 3) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa EPA / DHA/ALA (Omega 3) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa EPA / DHA/ALA (Omega 3) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
9.3 Turkey EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
9.4 Egypt EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
9.5 South Africa EPA / DHA/ALA (Omega 3) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global EPA / DHA/ALA (Omega 3) Sales and Market Share by Type (2015-2020)
10.2 Global EPA / DHA/ALA (Omega 3) Revenue and Market Share by Type (2015-2020)
10.3 Global EPA / DHA/ALA (Omega 3) Price by Type (2015-2020)
11 Global EPA / DHA/ALA (Omega 3) Market Segment by Application
11.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2015-2020)
11.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Application (2015-2020)
11.3 Global EPA / DHA/ALA (Omega 3) Price by Application (2015-2020)
12 Market Forecast
12.1 Global EPA / DHA/ALA (Omega 3) Sales, Revenue and Growth Rate (2021-2025)
12.2 EPA / DHA/ALA (Omega 3) Market Forecast by Regions (2021-2025)
12.2.1 North America EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.2.2 Europe EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.2.3 Asia-Pacific EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.2.4 South America EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.2.5 Middle East & Africa EPA / DHA/ALA (Omega 3) Market Forecast (2021-2025)
12.3 EPA / DHA/ALA (Omega 3) Market Forecast by Type (2021-2025)
12.3.1 Global EPA / DHA/ALA (Omega 3) Sales Forecast by Type (2021-2025)
12.3.2 Global EPA / DHA/ALA (Omega 3) Market Share Forecast by Type (2021-2025)
12.4 EPA / DHA/ALA (Omega 3) Market Forecast by Application (2021-2025)
12.4.1 Global EPA / DHA/ALA (Omega 3) Sales Forecast by Application (2021-2025)
12.4.2 Global EPA / DHA/ALA (Omega 3) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
【掲載企業】
EPAX、Polaris、Omega Protein、Golden Omega、GC Rieber、TASA、KD Pharma、Croda、Auqi
【免責事項】
https://www.globalresearch.jp/disclaimer